Graticule Asia Macro Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,561
Closed -$134K – 138
2026
Q2
$134K Buy
+5,561
New +$145K 0.01% 71
2017
Q2
– Sell
-58,000
Closed -$1.98M – 144
2017
Q1
$1.98M Buy
+58,000
New +$1.93M 0.12% 100

Other funds holding PFE

Graticule Asia Macro Advisors's PFE Position: Q3 2026 in Review

Graticule Asia Macro Advisors sold out of Pfizer (PFE) in Q3 2026, closing a stake of 5,561 shares — an estimated $134K sold.

Graticule Asia Macro Advisors first reported a position in PFE in Q1 2017 and held it in 2 quarters. The position peaked at $1.98M in Q1 2017. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Graticule Asia Macro Advisors reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 5,561 Pfizer shares in Q3 2026, an estimated $134K.
  • Graticule Asia Macro Advisors first reported a position in Pfizer in Q1 2017 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Pfizer position peaked at $1.98M in Q1 2017.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.